# OnCo record eclipse-psma (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/eclipse-psma/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "eclipse-psma", "NCT05204927" ;
  schema:name "ECLIPSE"@en ;
  schema:description "Curium's PSMA radioligand met its progression endpoint; survival data and an FDA filing are pending."@en ;
  schema:url <https://onco.cc/trials/eclipse-psma/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05204927> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2022-02-14" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:drugs <https://onco.cc/drugs/lu177-psma-it/> ;
  onco:companies <https://onco.cc/companies/curium/> .